Clinical Trial Update: A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC) [NA]

View source ↗

Summary

A Clinical Trials update announcing a study to evaluate CG-102-12C in GPC3-positive advanced hepatocellular carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CG-102-12C

Snippet

Sponsor: Zhejiang University | Conditions: Advanced Hepatocellular Carcinoma (HCC) | NA | Status: RECRUITING